2.3316
03-9月-25 11:11:27
15 分の遅延
株式
+0.1216
+5.50%
本日の幅
2.1000 - 2.3316
ISIN
N/A
ソース
NASDAQ
Lisata Therapeutics’ Director and Scientific Founder of the CendR Platform™ Technology, Erkki Ruoslahti, M.D., Ph.D., Receives 2022 Albert Lasker Basic Medical Research Award
29 9 2022 05:00:01 提供 Nasdaq GlobeNewswire